Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Accumulated Expenses (2016 - 2025)

Rockwell Medical's Accumulated Expenses history spans 16 years, with the latest figure at $4.3 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 30.88% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, down 30.88%, while the annual FY2025 figure was $4.3 million, 30.88% down from the prior year.
  • Accumulated Expenses reached $4.3 million in Q4 2025 per RMTI's latest filing, up from $3.9 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $7.7 million in Q4 2022 to a low of $3.8 million in Q2 2023.
  • Average Accumulated Expenses over 5 years is $5.1 million, with a median of $4.6 million recorded in 2022.
  • Peak YoY movement for Accumulated Expenses: soared 63.91% in 2024, then tumbled 38.55% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $5.1 million in 2021, then soared by 51.32% to $7.7 million in 2022, then decreased by 7.18% to $7.1 million in 2023, then decreased by 12.23% to $6.3 million in 2024, then tumbled by 30.88% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Accumulated Expenses are $4.3 million (Q4 2025), $3.9 million (Q3 2025), and $4.1 million (Q2 2025).